SS
VERA icon

SBI Securities’s Vera Therapeutics VERA Stock Holding History

SBI Securities’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$86 Buy
2
+1
+100% +$37 ﹤0.01% 3543
2026
Q1 		$40 Sell
1
-1
-50% -$43 ﹤0.01% 3622
2025
Q4 		$101 Hold
2
– – ﹤0.01% 3400
2025
Q3 		$58 Sell
2
-105
-98% -$2.43K ﹤0.01% 3669
2025
Q2 		$2.52K Buy
107
+106
+10,600% +$2.38K ﹤0.01% 2289
2025
Q1 		$24 Hold
1
– – ﹤0.01% 3820
2024
Q4 		$42 Buy
+1
New +$44 ﹤0.01% 3678

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

SBI Securities's VERA Position: Q2 2026 in Review

SBI Securities increased its Vera Therapeutics (VERA) stake by 100% in Q2 2026, buying an estimated $37 and bringing the position to 2 shares worth $86. The position accounts for ﹤0.01% of the portfolio, ranked #3543.

SBI Securities first reported a position in VERA in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.52K in Q2 2025. 220 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • SBI Securities held 2 shares of Vera Therapeutics worth $86 as of Q2 2026.
  • SBI Securities bought 1 Vera Therapeutics share in Q2 2026, an estimated $37.
  • Vera Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3543 holding.
  • SBI Securities first reported a position in Vera Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Vera Therapeutics position peaked at $2.52K in Q2 2025.
  • 220 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.